{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-081023","form_type":"8-K","ticker":"CERO","cik":"0001870404","company_name":"CERO THERAPEUTICS HOLDINGS, INC.","filed_at":"2024-09-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.035032+00:00","generated_at":"2026-05-31T02:32:26.058566+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CFO Charles R. Carter to depart CERo Therapeutics; successor search underway","bullets":["CFO Charles R. Carter informed Board he will leave on Sept 30, 2024 for a role at another public company.","Board has commenced a search for a new CFO; Carter will assist with transition for a brief period.","Carter's departure is effective Sept 30, 2024; no successor named yet."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-081023","json":"https://secwatch.observer/filing/0001213900-24-081023.json","markdown":"https://secwatch.observer/filing/0001213900-24-081023.md","text":"https://secwatch.observer/filing/0001213900-24-081023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1870404/000121390024081023/0001213900-24-081023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1870404/000121390024081023/ea021534602-8k_cerothera.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T02:32:26.058566+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b44936b011","claim":"Charles R. Carter resigned as Chief Financial Officer at CERO THERAPEUTICS HOLDINGS, INC..","evidence_excerpt":"On September 17, 2024, the Chief Financial Officer of CERo Therapeutics Holdings, Inc. (the “ Company ”), Charles R. Carter, informed the Board of Directors of the Company (the “ Board ”) that he expects to accept a new position with another publicly-traded company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1870404/000121390024081023/0001213900-24-081023-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}